Andrea Burton

1.9k total citations
26 papers, 1.4k citations indexed

About

Andrea Burton is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Andrea Burton has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Surgery and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Andrea Burton's work include Immunotherapy and Immune Responses (3 papers), Statistical Methods and Bayesian Inference (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Andrea Burton is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Statistical Methods and Bayesian Inference (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Andrea Burton collaborates with scholars based in United Kingdom, United States and Canada. Andrea Burton's co-authors include Douglas G. Altman, Roger Holder, Patrick Royston, Stirling Bryan, Lucinda Billingham, Ly‐Mee Yu, Oliver Rivero‐Arias, Peter Cooke, Nicholas D. James and Raji Ganesan and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Andrea Burton

26 papers receiving 1.4k citations

Peers

Countries citing papers authored by Andrea Burton

Since Specialization

Citations

This map shows the geographic impact of Andrea Burton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Burton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Burton more than expected).

Fields of papers citing papers by Andrea Burton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Burton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Burton. The network helps show where Andrea Burton may publish in the future.

Co-authorship network of co-authors of Andrea Burton

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Burton. A scholar is included among the top collaborators of Andrea Burton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Burton. Andrea Burton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neuroleptic Malignant Syndrome (NMS) on Clozapine with a Potential Atypical Interaction with Paliperidone 2021 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Andrea Burton	4
2	Disposition into Adipose Tissue Determines Accumulation and Elimination Kinetics of the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Mice 2015 ·Drug Metabolism and Disposition ·Gunther Hartmann, Sanjeev Kumar, Douglas G. Johns, Ferdous Gheyas, David E. Gutstein, Xiaolan Shen, Andrea Burton, (unknown), Robert Lutz, Travis C. Jackson, C.M. Chavez-Eng, Kaushik Mitra	13
3	Building WHO's global Strategy for Traditional Medicine 2015 ·European Journal of Integrative Medicine ·Andrea Burton, Michael L. Smith, Torkel Falkenberg	38
4	Evaluation of software for multiple imputation of semi-continuous data 2007 ·Statistical Methods in Medical Research ·Ly‐Mee Yu, Andrea Burton, Oliver Rivero‐Arias	75
5	Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data 2007 ·Clinical Trials ·Andrea Burton, Lucinda Billingham, Stirling Bryan	110
6	The design of simulation studies in medical statistics 2006 ·Statistics in Medicine ·Andrea Burton, Douglas G. Altman, Patrick Royston, Roger Holder	492
7	Delaying Radiotherapy for the Delivery of Adjuvant Chemotherapy in the Combined Modality Treatment of Early Breast Cancer: Is It Disadvantageous and Could Combined Treatment be the Answer? 2005 ·Clinical Oncology ·S. Bowden, Indrajit Fernando, Andrea Burton	11
8	Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines 2004 ·British Journal of Cancer ·Andrea Burton, Douglas G. Altman	164
9	A retrospective evaluation of the feasibility of intrapatient dose escalation as appropriate methodology for dose-ranging studies for combination cytotoxic regimens 2003 ·Cancer Chemotherapy and Pharmacology ·(unknown), Christopher Poole, V.R. Archer, Neil Steven, Andrea Burton	7
10	A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin’s lymphoma 2003 ·Annals of Oncology ·E.M. Bessell, Andrea Burton, Alexandria Porcia Haynes, J. Glaholm, J. A. Child, M.H. Cullen, J. M. Davies, Graeme Smith, Ian O. Ellis, Andrew Jack, E. L. Jones	12
11	Prospective Randomized Comparison of Dacarbazine (DTIC) Versus DTIC Plus Interferon-Alpha (IFN-α) in Metastatic Melanoma 2001 ·Clinical Oncology ·Anna Marie P. Young, J.R. Marsden, Andrew Goodman, Andrea Burton, Janet Dunn	49
12	In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase 2001 ·Gene Therapy ·(unknown), Mei‐Jou Chen, (unknown), Andrea Burton, David A. Anderson, Vivien Mautner, (unknown), D J Kerr	71
13	ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial 2001 ·British Journal of Cancer ·Barry W. Hancock, W. Gregory, M.H. Cullen, G. Vaughan Hudson, Andrea Burton, Peter J. Selby, K.A. MacLennan, Andrew Jack, E.M. Bessell, Peter J. Smith, DC Linch, (unknown)	16
14	Folic acid: Is self reported use of supplements accurate?: Table 1 2001 ·Journal of Epidemiology & Community Health ·Andrea Burton, (unknown), (unknown)	22
15	A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix 2000 ·Annals of Oncology ·J. Herod, Andrea Burton, (unknown), Jeffrey Tobias, David Luesley, (unknown), Janet Dunn, Christopher Poole	34
16	Phase II clinical trials of cisplatin-then-paclitaxel and paclitaxel-then-cisplatin in patients with previously untreated advanced epithelial ovarian cancer 2000 ·Annals of Oncology ·Christopher Poole, Timothy Perren, Andrea Burton, (unknown), (unknown), J. Mould, D. Spooner, David Luesley, Karen K. L. Chan, S. Sturman, Helena Earl	2
17	Bcl‐2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy 2000 ·British Journal of Urology ·Peter Cooke, Nicholas D. James, Raji Ganesan, Andrea Burton, Lawrence S. Young, D. M. A. WALLACE	59
18	CD40 expression in bladder cancer 1999 ·The Journal of Pathology ·Peter Cooke, Nicholas D. James, Raji Ganesan, Michael B. Wallace, Andrea Burton, Lawrence S. Young	46
19	Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer 1999 ·British Journal of Cancer ·(unknown), M J Langman, Janet Dunn, J Whiting, Andrea Burton, M T Hallissey, J W L Fielding, D J Kerr	16
20	CD40 expression in bladder cancer 1999 ·The Journal of Pathology ·Peter Cooke, Nicholas D. James, Raji Ganesan, Michael B. Wallace, Andrea Burton, Lawrence S. Young	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact